Cosmos Health is at a turning point in its journey. We have aligned every business unit around a common goal: creating a global healthcare and life sciences platform that integrates pharmaceuticals, ...
Oliver Bathe walks through addressing the surge in papillary thyroid cancer incidence by refining cancer care through ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
A new randomized study finds that a lab test that reads tumor genes can identify which patients with recurrent prostate ...
The company plans to launch in 2026 a program that will provide labs with scanners free of charge in exchange for volume-based payments for biomarker tests.
Data highlights ability of Akari’s ADC payload, PH1, to suppress the levels of the AR-V7 receptor that is responsible for driving hormone refractory prostate cancer progression ...
The Company will provide an update on its novel Doxorubicin containing Microneedle Array (D-MNA) treatment to non-invasively ...
Researchers from Johns Hopkins Kimmel Cancer Centre, Johns Hopkins All Children's Hospital, and other institutions have developed a new urine-based test ...
Some conservatives are targeting people and organizations they believe disparaged Charlie Kirk after his death.
On July 30, 2025, U.S. President Donald Trump announced a 50 percent tariff on Brazilian exports, justifying this measure not by currency manipulation or unfair trade practices, but as a response to ...
The EU is exploring Ethereum and Solana for its digital euro, marking a shift toward public blockchains over private models like China’s CBDC, according to the FT. The European Union is reportedly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback